How NASCAR Cup’s playoff-deciding race led to “frustration and disbelief”
A solid race and no surprise winners at Darlington was all Chris Buescher ensure his place in the 2024 NASCAR Cup playoffs, but fate – and Chase Briscoe – had other ideas.The RFK Racing Ford driver entered the regular season finale with a 21-point buffer over Bubba Wallace, holding the 16th and final spot in Read More
Wolff: Time for McLaren to make tough call on team orders
Mercedes team boss Toto Wolff believes McLaren needs to decide if it will throw its full backing behind Lando Norris in his fight for the title.Norris qualified on pole for Sunday’s Italian Grand Prix but was overtaken in turn four on the opening lap by team-mate Oscar Piastri as Ferrari’s Charles Leclerc ultimately went on Read More
How to watch WRC’s Acropolis Rally Greece: schedule and line-up
Thierry Neuville is edging closer towards his maiden WRC crown as finishing second at last month’s Rally Finland extended his advantage at the top.The Hyundai driver arrived in Scandinavia with just an eight-point advantage over team-mate Ott Tanak, but a stage three crash has left the 2019 world champion 31 points behind Neuville.Sebastien Ogier is Read More
An Ozempic rival, exploding airplane tires, Elon Musk vs. Brazil: Business news roundupAn Ozempic rival, exploding airplane tires, Elon Musk vs. Brazil: Business news roundup
Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently held by Ozempic-maker Novo Nordisk (NVO) and Eli Lilly (LLY), the producer of Zepbound. Read more… Viking Therapeutics (VKTX) is one of several pharma companies racing to break up the weight loss drug duopoly currently Read More
Residing in poverty tied to worse breast cancer outcomesResiding in poverty tied to worse breast cancer outcomes
Women residing in persistently impoverished neighborhoods have worse breast cancer outcomes, according to a study published online Aug. 29 in JAMA Network Open.
Ozempic could delay ageing, researchers suggestOzempic could delay ageing, researchers suggest
New studies suggest the weight loss drug could be used to treat a range of issues, including heart failure. New studies suggest the weight loss drug could be used to treat a range of issues, including heart failure.
Obesity Drug Wegovy Prevents Covid Deaths, Study SuggestsObesity Drug Wegovy Prevents Covid Deaths, Study Suggests
People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear. People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear.
Medication-related osteonecrosis of the jaw is prevalent in patients with breast cancerMedication-related osteonecrosis of the jaw is prevalent in patients with breast cancer
1. The cumulative incidence of medication-related osteonecrosis of the jaw (MRONJ) in patients with breast cancer bone metastases was much higher compared to the available data reported in the literature thus far. Evidence Rating Level: 2 (Good) MRONJ is a common side effect of antiresorptive therapeutics such as bisphosphonates and denosumab which are used in
The post Medication-related osteonecrosis of the jaw is prevalent in patients with breast cancer first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
Wegovy could prevent COVID-19 deaths, study showsWegovy could prevent COVID-19 deaths, study shows
A new analysis of a clinical trial of semaglutide — the active ingredient in Wegovy — showed that the popular weight loss drug reduced the risk of Covid-19 deaths among patients with heart disease. Read more… A new analysis of a clinical trial of semaglutide — the active ingredient in Wegovy — showed that Read More
Semaglutide reduces COVID-19 related deaths in patients with obesity and cardiovascular diseaseSemaglutide reduces COVID-19 related deaths in patients with obesity and cardiovascular disease
Semaglutide, the popular anti-obesity drug, reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established cardiovascular disease (CVD) without diabetes, according to a new study published in JACC. The results will be published simultaneously with a presentation at the European Society of Cardiology (ESC) Conference 2024 in Read More